Effectiveness of darbepoetin alfa administered every 3 weeks on clinical outcomes in patients with hematologic malignancies and chemotherapy-induced anemia.

被引：0
|
作者：
Boccia, RV
Silberstein, PT
Tchekmedyian, S
Tomita, D
Rossi, G
Otterson, G
机构：
[1] Ctr Canc & Blood Disorders, Bethesda, MD USA
[2] Creighton Univ, Omaha, NE 68178 USA
[3] Pacific Shores Med Grp, Huntington Beach, CA USA
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
[5] Ohio State Univ, Columbus, OH 43210 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3767
引用
收藏
页码：20B / 20B
页数：1
相关论文
共 50 条
  • [1] The effectiveness of darbepoetin alfa administered every 3 weeks on hematologic outcomes and quality of life in older patients with chemotherapy-induced anemia
    Boccia, Ralph
    Lillie, Tom
    Tomita, Dianne
    Balducci, Lodovico
    ONCOLOGIST, 2007, 12 (05): : 584 - 593
  • [2] Effectiveness of darbepoetin alfa administered every three weeks to elderly patients with chemotherapy-induced anemia
    Gasent, J. M.
    Bermejo, J. C., II
    Lopez, P.
    Domenech, M.
    Sanchez-Rovira, P.
    Villadiego, K.
    de Pedro, C.
    Iturralde, P.
    Gasquet, J. A.
    Rodriguez, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Darbepoetin alfa administered once every three weeks is effective for treating chemotherapy-induced anemia.
    Canon, JL
    Bodoky, G
    Mateos, MV
    Bastit, L
    Ferreira, I
    Amado, R
    Vansteenkiste, J
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S216 - S216
  • [4] An evaluation of the effectiveness of darbepoetin alfa 300 mcg every 3 weeks (Q3W) on clinical outcomes in cancer patients with chemotherapy-induced anemia.
    Boccia, RV
    Liu, DL
    Silberstein, P
    Tchekmedyian, S
    Tomita, D
    Rossi, G
    Otterson, G
    BLOOD, 2004, 104 (11) : 412B - 413B
  • [5] Darbepoetin alfa administered every three weeks is effective for the treatment of chemotherapy-induced anemia
    Boccia, Ralph
    Malik, Imtiaz A.
    Raja, Vinay
    Kahanic, Stephen
    Liu, Randall
    Lillie, Tom
    Tomita, Dianne
    Clowney, Billy
    Silberstein, Peter
    ONCOLOGIST, 2006, 11 (04): : 409 - 417
  • [6] Darbepoetin alfa dosed every 3 weeks in chemotherapy-induced anemia in patients with lung cancer
    Barata, F
    Parente, B
    Teixeira, E
    Barroso, A
    Figueiredo, A
    Conde, S
    LUNG CANCER, 2005, 49 : S331 - S331
  • [7] Rapid correction of anemia with darbepoetin alfa once every 3 weeks in chemotherapy-induced anemia
    Grangeia, L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 384 - 385
  • [8] Therapeutic interchange of darbepoetin alfa for epoetin alfa for chemotherapy-induced anemia.
    Blamble, DA
    Shermock, KM
    Nesbit, TW
    Pinto, B
    Fetting, J
    PHARMACOTHERAPY, 2004, 24 (10): : 1477 - 1477
  • [9] Darbepoetin alfa administered every 2 weeks alleviates anemia in cancer patients receiving chemotherapy
    Glaspy, JA
    Tchekmedyian, NS
    ONCOLOGY-NEW YORK, 2002, 16 (10): : 23 - 29
  • [10] Cost-effectiveness of once weekly epoetin alfa and darbepoetin alfa in treating chemotherapy-induced anemia.
    Ben-Hamadi, R
    Duh, MS
    Henchler, A
    McKenzie, S
    Fastenau, J
    Piech, CT
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 551S - 551S
12345